Physician profile
Nancy M Wright
NPI 1134144272
$19,960.51
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $5,126 · 2020: $10K · 2021: $2,803 · 2022: $1,993.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $13,958.30 | 2019-2022 | |
| Abbvie INC. | $2,933.41 | 2019-2022 | |
| Cgg Medical INC | $1,200.00 | 2022 | |
| Xeris Pharmaceuticals, INC. | $301.49 | 2020-2022 | |
| Novo Nordisk INC | $280.22 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $242.85 | 2020-2022 | |
| Ascendis Pharma Endocrinology INC | $161.01 | 2022 | |
| Lilly USA, LLC | $110.32 | 2019-2021 | |
| Dexcom, INC. | $93.45 | 2019-2020 | |
| Zealand Pharma US, INC. | $72.44 | 2021-2022 | |
| Abbott Laboratories | $69.76 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $66.12 | 2019 | |
| Endo Pharmaceuticals INC. | $61.41 | 2019-2022 | |
| Welch Allyn | $58.85 | 2021 | |
| Alexion Pharmaceuticals, INC. | $58.48 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $55.11 | 2019-2022 | |
| Lifescan, INC. | $53.33 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $41.29 | 2019-2020 | |
| Ultragenyx Pharmaceutical INC. | $38.55 | 2021-2022 | |
| Becton, Dickinson and Company | $34.36 | 2021 | |
| Medtronic Minimed, INC. | $28.83 | 2019-2020 | |
| Tandem Diabetes Care, INC. | $25.98 | 2019-2020 | |
| Ibsa Pharma INC. | $14.95 | 2022 |
Research and ownership
$23,500.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.